Semaglutide is also the active ingredient in several weight loss medications, including: Although semaglutide isnt Food and Drug Administration (FDA)-approved to treat nonalcoholic fatty liver disease (NAFLD), research suggests that semaglutide may help reduce fat in the liver, likely due to its ability to aid weight loss
From $50/mo With Medicare, if you qualify Compounded from $90 No membership or subscription fees Free 15-minute consult, no obligation
The PlexusDx Precision Peptide Genetic Test examines predispositions in key GLP-1 receptor and metabolic pathways (including GIPR rs1800437, GLP1R rs6923761, and FTO rs9939609 variants)
GLPs as Preventative Medicine, Not a Last Resort We often treat medication as a failuresomething you turn to only when things are already broken
they're stories of reclaimed vitality
Many plans cover GLP-1s for specific diagnoses (like diabetes or OSA) but exclude or restrict coverage for weight loss/obesity